Add to ORKGEvaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis: an in vitro and in vivo simulation usin
Infective endocarditis is associated with significant clinical mortality and morbidity. With the inc...
We describe 3 patients with left-sided staphylococcal endocarditis (1 with methicillin-susceptible S...
The best therapeutic approach for treating MRSA endocarditis remains unknown, particularly in cases ...
Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis: an in vitro and ...
Assessment of the place of daptomycin in the treatment of endocarditis and bacteraemia requires assi...
The in vivo efficacy of daptomycin, a new cell wall-active anti-gram-positive-bacterial agent, was c...
Background: Endocarditis and bacteraemia are devastating infections with high mortality. Gram-positi...
doi:10.1093/jac/dkl406 Efficacy of daptomycin in the treatment of experimental endocarditis due to s...
BACKGROUND: Alternative therapies for Staphylococcus aureus bacteremia and endocarditis are needed. ...
ObjectivesAmong viridans group streptococcal infective endocarditis (IE), the Streptococcus mitis gr...
Objective: Infective endocarditis (IE) carries a high risk of cardiac morbidity and mortality, despi...
none9noanoneBASSETTI, MATTEO; Ansaldi, Filippo; De Florentiis, Daniela; Righi, Elda; Pea, Federico; ...
BACKGROUND: Daptomycin is a novel cyclic lipopeptide whose bactericidal activity is not affected by ...
Daptomycin is a cyclic lipopeptide with potent bactericidal activity against Gram-positive organisms...
The use of daptomycin in Gram-positive left-sided infective endocarditis (IE) has significantly incr...
Infective endocarditis is associated with significant clinical mortality and morbidity. With the inc...
We describe 3 patients with left-sided staphylococcal endocarditis (1 with methicillin-susceptible S...
The best therapeutic approach for treating MRSA endocarditis remains unknown, particularly in cases ...
Evaluation of daptomycin treatment of Staphylococcus aureus bacterial endocarditis: an in vitro and ...
Assessment of the place of daptomycin in the treatment of endocarditis and bacteraemia requires assi...
The in vivo efficacy of daptomycin, a new cell wall-active anti-gram-positive-bacterial agent, was c...
Background: Endocarditis and bacteraemia are devastating infections with high mortality. Gram-positi...
doi:10.1093/jac/dkl406 Efficacy of daptomycin in the treatment of experimental endocarditis due to s...
BACKGROUND: Alternative therapies for Staphylococcus aureus bacteremia and endocarditis are needed. ...
ObjectivesAmong viridans group streptococcal infective endocarditis (IE), the Streptococcus mitis gr...
Objective: Infective endocarditis (IE) carries a high risk of cardiac morbidity and mortality, despi...
none9noanoneBASSETTI, MATTEO; Ansaldi, Filippo; De Florentiis, Daniela; Righi, Elda; Pea, Federico; ...
BACKGROUND: Daptomycin is a novel cyclic lipopeptide whose bactericidal activity is not affected by ...
Daptomycin is a cyclic lipopeptide with potent bactericidal activity against Gram-positive organisms...
The use of daptomycin in Gram-positive left-sided infective endocarditis (IE) has significantly incr...
Infective endocarditis is associated with significant clinical mortality and morbidity. With the inc...
We describe 3 patients with left-sided staphylococcal endocarditis (1 with methicillin-susceptible S...
The best therapeutic approach for treating MRSA endocarditis remains unknown, particularly in cases ...